• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Mira Pharmaceuticals released FY2025 9 Months Earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -1.3776
04:00
Mira Pharmaceuticals released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.1774 (forecast USD -0.08)
04:00
Oct15
Mira Pharmaceuticals Announces Mira-55 Study Results in Chronic Inflammatory Pain Animal Models
20:02
Sep30
MIRA Pharmaceuticals Completed Acquisition of SKNY Pharmaceuticals
11:30
Aug15
Mira Pharmaceuticals released FY2025 Semi-Annual Earnings on August 14 EST, with actual revenue of USD 0 and EPS of USD -0.1913
03:00
Mira Pharmaceuticals released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0905 (forecast USD -0.13)
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -22.69 M, EPS -1.1774

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -1.538 M, EPS -0.0905

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.784 M, EPS -0.1071

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More